Haley Ellis
Family · Watertown, SDNPI 1306485172
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,526 of the $4,948 with a category attached, or 71.3%. 23 manufacturers reported payments, led by Intuitive Surgical at 25.0% of the total. Reporting peaked in 2024 at $2,146 and has fallen 65.6% since, to $739 in 2025. Among family clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $24.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Mylan Specialty L.p.$882
- AstraZeneca$873
- Johnson & Johnson$218
- Actelion Pharmaceuticals US, Inc.$192
- Verona Pharma, Inc.$173
- plus $1K from 17 others
What the payments were for
- Travel & lodging$1,23625%
- Food & beverage$3,52671%
- Education$1864%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $1,236 |
| Mylan Specialty L.p. | 49 | $882 |
| AstraZeneca | 38 | $873 |
| Johnson & Johnson | 17 | $218 |
| Actelion Pharmaceuticals US, Inc. | 4 | $192 |
| Verona Pharma, Inc. | 7 | $173 |
| E.r. Squibb & Sons, L.L.C. | 9 | $165 |
| Grifols USA, LLC | 10 | $164 |
| Baxter Healthcare | 10 | $162 |
| GSK | 9 | $160 |
| Insmed, Inc. | 8 | $134 |
| Boehringer Ingelheim | 6 | $128 |
| Sanofi | 6 | $126 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $80 |
| Novartis | 4 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Bayer | 3 | $42 |
| Sanofi US Services Inc. | 1 | $22 |
| Amgen | 1 | $19 |
| Itamar Medical Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,091
How this compares
$4,948 in reported general payments places this provider in the 95th percentile of 588 family providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 264 | $193,494 |
| Spiriva RespimatTiotropium Bromide | 30 | $15,780 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $14,890 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,379 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,534 |
| Azithromycin | 78 | $2,658 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,411 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $2,087 |
| Montelukast Sodium | 146 | $1,414 |
| Ventolin HfaAlbuterol Sulfate | 11 | $723 |
| Pantoprazole Sodium | 63 | $578 |
| Potassium Chloride | 16 | $463 |
| Fluticasone Propionate | 69 | $414 |
| Prednisone | 78 | $288 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $160 | $198,028276 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $128 | $21,15941 claims |
| AstraZenecaBreztri Aerosphere | $873 | $14,89019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 588 family providers in South Dakota.
Other family in Watertown
- Kristina RieffenbergerWatertown$4K
- Allison TracyWatertown$2K
- Brittany WangsnessSioux Falls$79K
- Stephanie PreisterSioux Falls$12K
- Claudia HouglandRapid City$9K
- Maria AzpeitiaDakota Dunes$8K
- Michelle VanhoveSioux Falls$7K
- Sandra EricksonHerreid$7K
- Melissa OwensRapid City$6K
- Heidi FurthSioux Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.